Bio Protocol to Launch dCLINIC v.1.0 in Q3 2025

According to relevant media reports, BIO Protocol secured $6.9 million in seed funding on September 17, 2025. The round was backed by prominent investors including Maelstrom Capital, Mechanism Capital, Animoca Brands, Zee Prime Capital, Mirana Ventures, Foresight Ventures, Big Brain Holdings, and Panga Capital.BIO Protocol is a financial infrastructure platform designed for the DeSci (Decentralized Science) sector, aiming to accelerate the flow of capital and talent into on-chain scientific research. Through BIO Protocol's auction contracts, bioDAOs can raise funds to support research projects, intellectual property assets, and other biotechnology-related organizations. This innovative model offers new funding channels for scientific research and drives on-chain innovation in traditional research financing.Since its launch, BIO Protocol has experienced rapid growth. On January 3, 2025, BIO was officially listed for trading and subsequently became available on Binance and other major exchanges. On April 1, 2025, BIO Protocol released the V1 protocol upgrade, introducing Launchpad functionality and further enhancing the protocol's feature set. In the same month, Coinbase added Bio Protocol (BIO) to its asset roadmap, demonstrating market recognition of the project’s value. Additionally, on May 20, 2025, BIO Protocol introduced a linear unlocking proposal for team and advisor tokens, highlighting the project's transparency and long-term commitment to its ecosystem.